Amgen

Amgen signs licensing deal for Regenxbio gene therapy technology
Bizjournals.com
Mon, 05/16/16 - 11:44 am
Amgen
gene therapy
Regenxbio
NAV technology
Amgen Or Sanofi - Who is More Desperate for Medivation?
Bidness, ETC
Fri, 05/13/16 - 04:13 pm
Amgen
Sanofi
Medivation
Pfizer
M&A
Cigna makes deals with Amgen, Sanofi for PCSK9 cholesterol drugs
Yahoo/Reuters
Wed, 05/11/16 - 11:22 am
Cigna
Amgen
Sanofi
Praulent
Repatha
PCSK9 inhibitors
Medivation succumbs to pressure to explore sale - sources
Reuters
Tue, 05/10/16 - 05:11 pm
Medivation
M&A
Pfizer
Sanofi
Amgen
Analysts Adjust Predictions on Medivation Buyout Price
24/7 Wall St
Mon, 05/9/16 - 09:26 am
Medivation
M&A
Sanofi
Pfizer
Amgen
Medivation: Better On Its Own?
Barron's
Fri, 05/6/16 - 10:58 am
Medivation
M&A
Sanofi
Pfizer
Amgen
Sanofi, Amgen cholesterol drugs win UK backing after price cuts
Yahoo/Reuters
Fri, 05/6/16 - 10:47 am
Sanofi
Amgen
UK
PCSK9 inhibitors
Repatha
Praluent
Amgen Said to Join Health-Care Pack Weighing Medivation Bids
Bloomberg
Thu, 05/5/16 - 02:06 pm
Amgen
Sanofi
Pfizer
Medivation
M&A
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Wed, 05/4/16 - 09:48 am
Amgen
Kyprolis
JNJ
Bristol-Myers Squibb
Multiple Myeloma
Darzalex
Empliciti
AbbVie
Takeda
Ninlaro
Regeneron Nips At Amgen And Pfizer's Heels In Pain Drug Race
Seeking Alpha
Tue, 05/3/16 - 09:46 pm
Regeneron
Amgen
Pfizer
painkillers
fasinumab
clinical trials
What Are Analysts Saying About Q1 At Biotech's Big 4? Amgen, Biogen, Celgene, Gilead
Forbes
Sat, 04/30/16 - 11:40 am
Amgen
Biogen
Celgene
Gilead Sciences
earnings
Amgen beats Street 1Q forecasts
Yahoo/AP
Thu, 04/28/16 - 06:05 pm
Amgen
earnings
Roche Still Waiting For The Big Push
Seeking Alpha
Tue, 04/26/16 - 09:55 am
Roche
ASCO
immuno-oncology
Amgen
Merck
Bristol-Myers Squibb
Amgen (AMGN): What to Expect from Q1 Earnings
Bidness, ETC
Sun, 04/24/16 - 12:02 pm
Amgen
earnings
Can Humira Still Dominate In 2022?
Seeking Alpha
Thu, 04/21/16 - 03:28 pm
Humira
Amgen
Bristol-Myers Squibb
Coherus Biosciences
Gilead Sciences
Intercept Pharma
JNJ
Novartis
Pfizer
New heart drugs struggle to win sales as doctors hold back
Yahoo/Reuters
Thu, 04/21/16 - 09:16 am
Novartis
Entresto
Sanofi
Amgen
Praluent
Repatha
physicians
Why Biotech Will Benefit from Higher Drug Prices
Barron's
Wed, 04/20/16 - 06:41 pm
biotech
drug pricing
JNJ
Gilead Sciences
Amgen
Biogen
Medivation: Biotech’s Most Wanted?
Barron's
Wed, 04/13/16 - 09:53 am
Medivation
M&A
Amgen
Gilead Sciences
Sanofi
AstraZeneca
Biotech: If M&A is the Answer, What’s the Question?
Barron's
Tue, 04/12/16 - 03:42 pm
biotech
M&A
Amgen
Biogen
Celgene
Gilead Sciences
New myeloma meds work better than the old, but they're far too expensive: Report
Fierce Biotech
Tue, 04/12/16 - 03:39 pm
Multiple Myeloma
Bristol-Myers Squibb
Amgen
Takeda
Empliciti
Kyprolis
Ninlaro
Celgene
Revlimid

Pages